Dow Jones Newswires: Roche developing coronavirus serology test

This post was originally published on this site

The Swiss drug maker said the Elecsys Anti-Sars-CoV-2 immunoassay is an in-vitro test to detect antibodies and assess the body’s immune reaction to Sars-CoV-2, better known as Covid-19, using human serum and plasma from a blood sample.

Add Comment